Alteration of The Intestinal Microbiome Among Coronary Artery Disease Patients

BackgroundIntestinal microbiome has been linked to several metabolic and chronic disorders, including coronary artery disease (CAD). Our study aimed to analyze the intestinal microbiome of CAD patients and compare it to the healthy controls.MethodsPubMed, Scopus, Embase, and Web of Science were sear...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American heart journal 2024-01, Vol.267, p.141-142
Hauptverfasser: Dean, Yomna E., Sabry, Samah S., Hassan, Noheir Ashraf Ibrahem Fathy, Shebl, Mohamed A., Yaqout, Yasmeen Essam, Tokunaga, Akiko, Anozie, Chukwuebuka, Elkoumi, Omar, Ahmed, Parisa, Elawady, Sameh Samir, Mady, Tamer, Nizam, Sana N., Elbahaie, Arwa, Elbahaie, Areeg, Samir, Omar Khalid, Habib, Omar Khalid, Etman, Yasser, Nizam, Rayees, Hazimeh, Yusef, Alazmy, Mohamed, Aiash, Hani
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 142
container_issue
container_start_page 141
container_title The American heart journal
container_volume 267
creator Dean, Yomna E.
Sabry, Samah S.
Hassan, Noheir Ashraf Ibrahem Fathy
Shebl, Mohamed A.
Yaqout, Yasmeen Essam
Tokunaga, Akiko
Anozie, Chukwuebuka
Elkoumi, Omar
Ahmed, Parisa
Elawady, Sameh Samir
Mady, Tamer
Nizam, Sana N.
Elbahaie, Arwa
Elbahaie, Areeg
Samir, Omar Khalid
Habib, Omar Khalid
Etman, Yasser
Nizam, Rayees
Hazimeh, Yusef
Alazmy, Mohamed
Aiash, Hani
description BackgroundIntestinal microbiome has been linked to several metabolic and chronic disorders, including coronary artery disease (CAD). Our study aimed to analyze the intestinal microbiome of CAD patients and compare it to the healthy controls.MethodsPubMed, Scopus, Embase, and Web of Science were searched using terms; such as “CAD” and “microbiome”. Only observational controlled studies were included. Analysis was conducted by RevMan software version 5.4.ResultsA significant association was found between the CAD group and increased Simpson and Shannon Indices compared with the control group (MD = 0.04, 95% CI = 0.03 to 0.05, p-value >0.00001 and MD = 0.11, 95% CI = 0.01 to 0.22, p-value = 0.03 respectively). Our analysis yielded a significant association between the CAD group and increased Prevotella genus (MD = 13.27, 95% CI = 4.12 to 22.42, p-value =0.004), Catenibacterium genus (MD = 0.09, 95% CI = 0.09 to 0.10, p-value >0.00001), Pseudomonas genus (MD = 0.54, 95% CI = 0.29 to 0.78, p-value >0.00001), and Subdoligranulum (MD = -0.06, 95% CI = -0.06b to -0.06, p-value 0.00001).ConclusionDysbiosis is an acceptable discriminatory marker of CAD. Decreased B.dorei and B.vulgatus among CAD patients suggests a protective role of these bacteria. Future clinical trials are necessary to investigate the potential benefit of supplementation of these bacteria in treating or preventing CAD.
doi_str_mv 10.1016/j.ahj.2023.08.058
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2899058521</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2899058521</sourcerecordid><originalsourceid>FETCH-LOGICAL-c701-a1e9931fc81fd1847b4bbb1ac8fa1e8e000f0c7434f362840445582ad62d4c273</originalsourceid><addsrcrecordid>eNotkEtPwzAQhC0EEqXwA7hZ4pywfiR2jlGAUqk8Dr1bTmrTRG1c7PTQf89W5bRa7czo2yHkkUHOgJXPQ263Q86Bixx0DoW-IjMGlcpKJeU1mQEAz7QCcUvuUhpwLbkuZ-Sz3k0u2qkPIw2erreOLsfJpakf7Y5-9F0MbR_2jtb7MP7QJsQw2niidUTbib70ydnk6DcmuHFK9-TG211yD_9zTtZvr-vmPVt9LZZNvco6BSyzzFWVYL7TzG-YlqqVbdsy22mPJ-2QzkOnpJBeIKYEKYtCc7sp-UZ2XIk5ebrEHmL4PSKtGcIxInEyXFcVvl9whip2UeETKUXnzSH2e6Q3DMy5NTMYbM2cWzOgDdrEHzvyYDw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2899058521</pqid></control><display><type>article</type><title>Alteration of The Intestinal Microbiome Among Coronary Artery Disease Patients</title><source>Elsevier ScienceDirect Journals</source><creator>Dean, Yomna E. ; Sabry, Samah S. ; Hassan, Noheir Ashraf Ibrahem Fathy ; Shebl, Mohamed A. ; Yaqout, Yasmeen Essam ; Tokunaga, Akiko ; Anozie, Chukwuebuka ; Elkoumi, Omar ; Ahmed, Parisa ; Elawady, Sameh Samir ; Mady, Tamer ; Nizam, Sana N. ; Elbahaie, Arwa ; Elbahaie, Areeg ; Samir, Omar Khalid ; Habib, Omar Khalid ; Etman, Yasser ; Nizam, Rayees ; Hazimeh, Yusef ; Alazmy, Mohamed ; Aiash, Hani</creator><creatorcontrib>Dean, Yomna E. ; Sabry, Samah S. ; Hassan, Noheir Ashraf Ibrahem Fathy ; Shebl, Mohamed A. ; Yaqout, Yasmeen Essam ; Tokunaga, Akiko ; Anozie, Chukwuebuka ; Elkoumi, Omar ; Ahmed, Parisa ; Elawady, Sameh Samir ; Mady, Tamer ; Nizam, Sana N. ; Elbahaie, Arwa ; Elbahaie, Areeg ; Samir, Omar Khalid ; Habib, Omar Khalid ; Etman, Yasser ; Nizam, Rayees ; Hazimeh, Yusef ; Alazmy, Mohamed ; Aiash, Hani</creatorcontrib><description>BackgroundIntestinal microbiome has been linked to several metabolic and chronic disorders, including coronary artery disease (CAD). Our study aimed to analyze the intestinal microbiome of CAD patients and compare it to the healthy controls.MethodsPubMed, Scopus, Embase, and Web of Science were searched using terms; such as “CAD” and “microbiome”. Only observational controlled studies were included. Analysis was conducted by RevMan software version 5.4.ResultsA significant association was found between the CAD group and increased Simpson and Shannon Indices compared with the control group (MD = 0.04, 95% CI = 0.03 to 0.05, p-value &gt;0.00001 and MD = 0.11, 95% CI = 0.01 to 0.22, p-value = 0.03 respectively). Our analysis yielded a significant association between the CAD group and increased Prevotella genus (MD = 13.27, 95% CI = 4.12 to 22.42, p-value =0.004), Catenibacterium genus (MD = 0.09, 95% CI = 0.09 to 0.10, p-value &gt;0.00001), Pseudomonas genus (MD = 0.54, 95% CI = 0.29 to 0.78, p-value &gt;0.00001), and Subdoligranulum (MD = -0.06, 95% CI = -0.06b to -0.06, p-value &lt;0.00001) compared with the control group. Another significant association was detected between the CAD group and decreased B.vulgatus and B.dorei (MD = -10.31, 95% CI = -14.78 to -5.84, p-value &gt;0.00001).ConclusionDysbiosis is an acceptable discriminatory marker of CAD. Decreased B.dorei and B.vulgatus among CAD patients suggests a protective role of these bacteria. Future clinical trials are necessary to investigate the potential benefit of supplementation of these bacteria in treating or preventing CAD.</description><identifier>ISSN: 0002-8703</identifier><identifier>EISSN: 1097-6744</identifier><identifier>DOI: 10.1016/j.ahj.2023.08.058</identifier><language>eng</language><publisher>Philadelphia: Elsevier Limited</publisher><subject>Bacteria ; Cardiovascular disease ; Clinical trials ; Coronary artery disease ; Coronary vessels ; Dysbacteriosis ; Heart diseases ; Intestine ; Microbiomes ; Patients ; Vein &amp; artery diseases</subject><ispartof>The American heart journal, 2024-01, Vol.267, p.141-142</ispartof><rights>Copyright Elsevier Limited Jan 2024</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Dean, Yomna E.</creatorcontrib><creatorcontrib>Sabry, Samah S.</creatorcontrib><creatorcontrib>Hassan, Noheir Ashraf Ibrahem Fathy</creatorcontrib><creatorcontrib>Shebl, Mohamed A.</creatorcontrib><creatorcontrib>Yaqout, Yasmeen Essam</creatorcontrib><creatorcontrib>Tokunaga, Akiko</creatorcontrib><creatorcontrib>Anozie, Chukwuebuka</creatorcontrib><creatorcontrib>Elkoumi, Omar</creatorcontrib><creatorcontrib>Ahmed, Parisa</creatorcontrib><creatorcontrib>Elawady, Sameh Samir</creatorcontrib><creatorcontrib>Mady, Tamer</creatorcontrib><creatorcontrib>Nizam, Sana N.</creatorcontrib><creatorcontrib>Elbahaie, Arwa</creatorcontrib><creatorcontrib>Elbahaie, Areeg</creatorcontrib><creatorcontrib>Samir, Omar Khalid</creatorcontrib><creatorcontrib>Habib, Omar Khalid</creatorcontrib><creatorcontrib>Etman, Yasser</creatorcontrib><creatorcontrib>Nizam, Rayees</creatorcontrib><creatorcontrib>Hazimeh, Yusef</creatorcontrib><creatorcontrib>Alazmy, Mohamed</creatorcontrib><creatorcontrib>Aiash, Hani</creatorcontrib><title>Alteration of The Intestinal Microbiome Among Coronary Artery Disease Patients</title><title>The American heart journal</title><description>BackgroundIntestinal microbiome has been linked to several metabolic and chronic disorders, including coronary artery disease (CAD). Our study aimed to analyze the intestinal microbiome of CAD patients and compare it to the healthy controls.MethodsPubMed, Scopus, Embase, and Web of Science were searched using terms; such as “CAD” and “microbiome”. Only observational controlled studies were included. Analysis was conducted by RevMan software version 5.4.ResultsA significant association was found between the CAD group and increased Simpson and Shannon Indices compared with the control group (MD = 0.04, 95% CI = 0.03 to 0.05, p-value &gt;0.00001 and MD = 0.11, 95% CI = 0.01 to 0.22, p-value = 0.03 respectively). Our analysis yielded a significant association between the CAD group and increased Prevotella genus (MD = 13.27, 95% CI = 4.12 to 22.42, p-value =0.004), Catenibacterium genus (MD = 0.09, 95% CI = 0.09 to 0.10, p-value &gt;0.00001), Pseudomonas genus (MD = 0.54, 95% CI = 0.29 to 0.78, p-value &gt;0.00001), and Subdoligranulum (MD = -0.06, 95% CI = -0.06b to -0.06, p-value &lt;0.00001) compared with the control group. Another significant association was detected between the CAD group and decreased B.vulgatus and B.dorei (MD = -10.31, 95% CI = -14.78 to -5.84, p-value &gt;0.00001).ConclusionDysbiosis is an acceptable discriminatory marker of CAD. Decreased B.dorei and B.vulgatus among CAD patients suggests a protective role of these bacteria. Future clinical trials are necessary to investigate the potential benefit of supplementation of these bacteria in treating or preventing CAD.</description><subject>Bacteria</subject><subject>Cardiovascular disease</subject><subject>Clinical trials</subject><subject>Coronary artery disease</subject><subject>Coronary vessels</subject><subject>Dysbacteriosis</subject><subject>Heart diseases</subject><subject>Intestine</subject><subject>Microbiomes</subject><subject>Patients</subject><subject>Vein &amp; artery diseases</subject><issn>0002-8703</issn><issn>1097-6744</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNotkEtPwzAQhC0EEqXwA7hZ4pywfiR2jlGAUqk8Dr1bTmrTRG1c7PTQf89W5bRa7czo2yHkkUHOgJXPQ263Q86Bixx0DoW-IjMGlcpKJeU1mQEAz7QCcUvuUhpwLbkuZ-Sz3k0u2qkPIw2erreOLsfJpakf7Y5-9F0MbR_2jtb7MP7QJsQw2niidUTbib70ydnk6DcmuHFK9-TG211yD_9zTtZvr-vmPVt9LZZNvco6BSyzzFWVYL7TzG-YlqqVbdsy22mPJ-2QzkOnpJBeIKYEKYtCc7sp-UZ2XIk5ebrEHmL4PSKtGcIxInEyXFcVvl9whip2UeETKUXnzSH2e6Q3DMy5NTMYbM2cWzOgDdrEHzvyYDw</recordid><startdate>202401</startdate><enddate>202401</enddate><creator>Dean, Yomna E.</creator><creator>Sabry, Samah S.</creator><creator>Hassan, Noheir Ashraf Ibrahem Fathy</creator><creator>Shebl, Mohamed A.</creator><creator>Yaqout, Yasmeen Essam</creator><creator>Tokunaga, Akiko</creator><creator>Anozie, Chukwuebuka</creator><creator>Elkoumi, Omar</creator><creator>Ahmed, Parisa</creator><creator>Elawady, Sameh Samir</creator><creator>Mady, Tamer</creator><creator>Nizam, Sana N.</creator><creator>Elbahaie, Arwa</creator><creator>Elbahaie, Areeg</creator><creator>Samir, Omar Khalid</creator><creator>Habib, Omar Khalid</creator><creator>Etman, Yasser</creator><creator>Nizam, Rayees</creator><creator>Hazimeh, Yusef</creator><creator>Alazmy, Mohamed</creator><creator>Aiash, Hani</creator><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope></search><sort><creationdate>202401</creationdate><title>Alteration of The Intestinal Microbiome Among Coronary Artery Disease Patients</title><author>Dean, Yomna E. ; Sabry, Samah S. ; Hassan, Noheir Ashraf Ibrahem Fathy ; Shebl, Mohamed A. ; Yaqout, Yasmeen Essam ; Tokunaga, Akiko ; Anozie, Chukwuebuka ; Elkoumi, Omar ; Ahmed, Parisa ; Elawady, Sameh Samir ; Mady, Tamer ; Nizam, Sana N. ; Elbahaie, Arwa ; Elbahaie, Areeg ; Samir, Omar Khalid ; Habib, Omar Khalid ; Etman, Yasser ; Nizam, Rayees ; Hazimeh, Yusef ; Alazmy, Mohamed ; Aiash, Hani</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c701-a1e9931fc81fd1847b4bbb1ac8fa1e8e000f0c7434f362840445582ad62d4c273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Bacteria</topic><topic>Cardiovascular disease</topic><topic>Clinical trials</topic><topic>Coronary artery disease</topic><topic>Coronary vessels</topic><topic>Dysbacteriosis</topic><topic>Heart diseases</topic><topic>Intestine</topic><topic>Microbiomes</topic><topic>Patients</topic><topic>Vein &amp; artery diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dean, Yomna E.</creatorcontrib><creatorcontrib>Sabry, Samah S.</creatorcontrib><creatorcontrib>Hassan, Noheir Ashraf Ibrahem Fathy</creatorcontrib><creatorcontrib>Shebl, Mohamed A.</creatorcontrib><creatorcontrib>Yaqout, Yasmeen Essam</creatorcontrib><creatorcontrib>Tokunaga, Akiko</creatorcontrib><creatorcontrib>Anozie, Chukwuebuka</creatorcontrib><creatorcontrib>Elkoumi, Omar</creatorcontrib><creatorcontrib>Ahmed, Parisa</creatorcontrib><creatorcontrib>Elawady, Sameh Samir</creatorcontrib><creatorcontrib>Mady, Tamer</creatorcontrib><creatorcontrib>Nizam, Sana N.</creatorcontrib><creatorcontrib>Elbahaie, Arwa</creatorcontrib><creatorcontrib>Elbahaie, Areeg</creatorcontrib><creatorcontrib>Samir, Omar Khalid</creatorcontrib><creatorcontrib>Habib, Omar Khalid</creatorcontrib><creatorcontrib>Etman, Yasser</creatorcontrib><creatorcontrib>Nizam, Rayees</creatorcontrib><creatorcontrib>Hazimeh, Yusef</creatorcontrib><creatorcontrib>Alazmy, Mohamed</creatorcontrib><creatorcontrib>Aiash, Hani</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><jtitle>The American heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dean, Yomna E.</au><au>Sabry, Samah S.</au><au>Hassan, Noheir Ashraf Ibrahem Fathy</au><au>Shebl, Mohamed A.</au><au>Yaqout, Yasmeen Essam</au><au>Tokunaga, Akiko</au><au>Anozie, Chukwuebuka</au><au>Elkoumi, Omar</au><au>Ahmed, Parisa</au><au>Elawady, Sameh Samir</au><au>Mady, Tamer</au><au>Nizam, Sana N.</au><au>Elbahaie, Arwa</au><au>Elbahaie, Areeg</au><au>Samir, Omar Khalid</au><au>Habib, Omar Khalid</au><au>Etman, Yasser</au><au>Nizam, Rayees</au><au>Hazimeh, Yusef</au><au>Alazmy, Mohamed</au><au>Aiash, Hani</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Alteration of The Intestinal Microbiome Among Coronary Artery Disease Patients</atitle><jtitle>The American heart journal</jtitle><date>2024-01</date><risdate>2024</risdate><volume>267</volume><spage>141</spage><epage>142</epage><pages>141-142</pages><issn>0002-8703</issn><eissn>1097-6744</eissn><abstract>BackgroundIntestinal microbiome has been linked to several metabolic and chronic disorders, including coronary artery disease (CAD). Our study aimed to analyze the intestinal microbiome of CAD patients and compare it to the healthy controls.MethodsPubMed, Scopus, Embase, and Web of Science were searched using terms; such as “CAD” and “microbiome”. Only observational controlled studies were included. Analysis was conducted by RevMan software version 5.4.ResultsA significant association was found between the CAD group and increased Simpson and Shannon Indices compared with the control group (MD = 0.04, 95% CI = 0.03 to 0.05, p-value &gt;0.00001 and MD = 0.11, 95% CI = 0.01 to 0.22, p-value = 0.03 respectively). Our analysis yielded a significant association between the CAD group and increased Prevotella genus (MD = 13.27, 95% CI = 4.12 to 22.42, p-value =0.004), Catenibacterium genus (MD = 0.09, 95% CI = 0.09 to 0.10, p-value &gt;0.00001), Pseudomonas genus (MD = 0.54, 95% CI = 0.29 to 0.78, p-value &gt;0.00001), and Subdoligranulum (MD = -0.06, 95% CI = -0.06b to -0.06, p-value &lt;0.00001) compared with the control group. Another significant association was detected between the CAD group and decreased B.vulgatus and B.dorei (MD = -10.31, 95% CI = -14.78 to -5.84, p-value &gt;0.00001).ConclusionDysbiosis is an acceptable discriminatory marker of CAD. Decreased B.dorei and B.vulgatus among CAD patients suggests a protective role of these bacteria. Future clinical trials are necessary to investigate the potential benefit of supplementation of these bacteria in treating or preventing CAD.</abstract><cop>Philadelphia</cop><pub>Elsevier Limited</pub><doi>10.1016/j.ahj.2023.08.058</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-8703
ispartof The American heart journal, 2024-01, Vol.267, p.141-142
issn 0002-8703
1097-6744
language eng
recordid cdi_proquest_journals_2899058521
source Elsevier ScienceDirect Journals
subjects Bacteria
Cardiovascular disease
Clinical trials
Coronary artery disease
Coronary vessels
Dysbacteriosis
Heart diseases
Intestine
Microbiomes
Patients
Vein & artery diseases
title Alteration of The Intestinal Microbiome Among Coronary Artery Disease Patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T14%3A11%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Alteration%20of%20The%20Intestinal%20Microbiome%20Among%20Coronary%20Artery%20Disease%20Patients&rft.jtitle=The%20American%20heart%20journal&rft.au=Dean,%20Yomna%20E.&rft.date=2024-01&rft.volume=267&rft.spage=141&rft.epage=142&rft.pages=141-142&rft.issn=0002-8703&rft.eissn=1097-6744&rft_id=info:doi/10.1016/j.ahj.2023.08.058&rft_dat=%3Cproquest_cross%3E2899058521%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2899058521&rft_id=info:pmid/&rfr_iscdi=true